Integer Holdings Co. (ITGR) Expected to Post Quarterly Sales of $361.04 Million

Brokerages forecast that Integer Holdings Co. (NYSE:ITGR) will post sales of $361.04 million for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Integer’s earnings, with estimates ranging from $360.00 million to $361.63 million. Integer posted sales of $359.59 million during the same quarter last year, which suggests a positive year over year growth rate of 0.4%. The business is scheduled to issue its next earnings report on Monday, February 26th.

According to Zacks, analysts expect that Integer will report full year sales of $361.04 million for the current year. For the next year, analysts expect that the company will post sales of $1.47 billion per share, with estimates ranging from $1.47 billion to $1.48 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that follow Integer.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, October 26th. The medical equipment provider reported $0.82 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.78 by $0.04. The firm had revenue of $363.31 million during the quarter, compared to the consensus estimate of $354.83 million. Integer had a net margin of 1.42% and a return on equity of 11.22%. The company’s revenue for the quarter was up 4.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.83 earnings per share.

Several equities analysts have recently issued reports on ITGR shares. BidaskClub downgraded shares of Integer from a “buy” rating to a “hold” rating in a research note on Saturday, November 4th. Northcoast Research downgraded shares of Integer from a “buy” rating to a “neutral” rating in a research note on Monday, October 23rd. They noted that the move was a valuation call. TheStreet downgraded shares of Integer from a “b-” rating to a “c+” rating in a research note on Thursday, November 9th. Zacks Investment Research raised shares of Integer from a “sell” rating to a “buy” rating and set a $51.00 target price for the company in a research note on Wednesday, December 27th. Finally, ValuEngine raised shares of Integer from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Integer currently has a consensus rating of “Hold” and an average price target of $51.00.

In other Integer news, VP Thomas J. Mazza sold 23,123 shares of Integer stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $46.16, for a total value of $1,067,357.68. Following the completion of the sale, the vice president now directly owns 26,123 shares of the company’s stock, valued at $1,205,837.68. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Gary J. Haire sold 731 shares of Integer stock in a transaction on Wednesday, January 3rd. The shares were sold at an average price of $44.89, for a total transaction of $32,814.59. Following the completion of the sale, the chief financial officer now directly owns 1,911 shares of the company’s stock, valued at $85,784.79. The disclosure for this sale can be found here. Insiders have sold 100,625 shares of company stock valued at $4,694,219 in the last three months. 4.80% of the stock is owned by insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. UBS Asset Management Americas Inc. increased its stake in Integer by 0.5% in the second quarter. UBS Asset Management Americas Inc. now owns 18,967 shares of the medical equipment provider’s stock valued at $820,000 after purchasing an additional 98 shares in the last quarter. TIAA CREF Investment Management LLC increased its stake in Integer by 0.6% in the second quarter. TIAA CREF Investment Management LLC now owns 123,410 shares of the medical equipment provider’s stock valued at $5,337,000 after purchasing an additional 740 shares in the last quarter. Quantbot Technologies LP increased its stake in Integer by 21.5% in the third quarter. Quantbot Technologies LP now owns 6,255 shares of the medical equipment provider’s stock valued at $319,000 after purchasing an additional 1,107 shares in the last quarter. Rhumbline Advisers increased its stake in Integer by 2.0% in the third quarter. Rhumbline Advisers now owns 61,908 shares of the medical equipment provider’s stock valued at $3,167,000 after purchasing an additional 1,235 shares in the last quarter. Finally, American International Group Inc. increased its stake in Integer by 6.1% in the third quarter. American International Group Inc. now owns 24,207 shares of the medical equipment provider’s stock valued at $1,238,000 after purchasing an additional 1,389 shares in the last quarter. 95.11% of the stock is owned by hedge funds and other institutional investors.

Integer (NYSE ITGR) opened at $49.05 on Monday. The stock has a market cap of $1,553.41, a price-to-earnings ratio of 77.86, a PEG ratio of 1.03 and a beta of 1.08. Integer has a 52 week low of $29.60 and a 52 week high of $55.20. The company has a debt-to-equity ratio of 1.95, a quick ratio of 1.37 and a current ratio of 2.58.

COPYRIGHT VIOLATION NOTICE: “Integer Holdings Co. (ITGR) Expected to Post Quarterly Sales of $361.04 Million” was published by American Banking News and is the property of of American Banking News. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/01/22/integer-holdings-co-itgr-expected-to-post-quarterly-sales-of-361-04-million.html.

Integer Company Profile

Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.

Get a free copy of the Zacks research report on Integer (ITGR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply